Gold Sodium Thiomalate and D-Penicillamine: A Controlled, Comparative Study in Patients with Pauciarticular and Polyarticular Juvenile Rheumatoid Arthritis

References

• Ansell B. M. Penicillamine, levamisole, and cytotoxic drugs. Arthritis in Childhood, T. D. Moore. Ross Laboratories, Columbus, Ohio 1981; 127
   Google Scholar
• Ansell B. M., Hall M. A., Ribero S. A comparative study of gold and penicillamine in seropositive juvenile chronic arthritis (juvenile rheumatoid arthritis). Ann Rheum Dis 1981; 40: 522
   Google Scholar
• Bojkinov I., Raikov K. Goldbehandlung bei Kindern mit rheumatoider Arthritis. Monatsschr Kinderheilkd 1970; 118: 444
   PubMedGoogle Scholar
• Brewer E. J., Bass J., Baum J., Cassidy J. T., Fink C., Jacobs J., Hanson V., Levinson J. E., Schaller J., Stillman J. S. Current proposed revision of JRA criteria. Arthritis Rheum 1977; 20(suppl.)195
   PubMedGoogle Scholar
• Brewer E. J., Giannini E. H., Barkley E. Gold therapy in the management of juvenile rheumatoid arthritis. Arthritis Rheum 1980; 23: 404
   PubMedGoogle Scholar
• Capell H. A., Hunter J. A., Rennie J. A. N., Murdoch R. M. Levamisole—a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis. J Rheumatol 1981; 8: 730
   PubMedGoogle Scholar
• Chaffman M., Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Auranofin. A preliminary review of its pharmacological properties and therapeutic use is rheumatoid arthritis. Drugs 1984; 27: 378
   PubMedGoogle Scholar
• Cooperating Clinics Committee of the American Rheumatism Association: A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 1973; 16: 353
   PubMed Web of Science ®Google Scholar
• Debendetti C, Tretbar H., Conigan J. J., jr. Gold therapy in juvenile rheumatoid arthritis. Ariz Med 1976; 33: 373
   PubMedGoogle Scholar
• Dixon A. St. J., Davies J., Dormandy T. L., Hamilton E. B. D., Holt P. J. L., Mason R. M., Thompson M., Weber J. C. P., Zutshi D. W. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis 1975; 34: 416
   PubMedGoogle Scholar
• Ghishan F. K., LaBrecque D. R., Younoszai K. Intrahepatic cholestasis after gold therapy in juvenile rheumatoid arthritis. J Pediatr 1978; 93: 1042
   PubMed Web of Science ®Google Scholar
• Giannini E. H., Brewer E. J. Standard methodology for segment I, II and III Pediatric Rheumatology Collaborative Study Group Studies. II. Analysis and presentation of data. J Rheumatol 1982; 9: 114
   PubMedGoogle Scholar
• Giannini E. H., Brewer E. J., Person D. A. Auranofin in the treatment of juvenile rheumatoid arthritis. J Pediatr 1983; 102: 138
   PubMedGoogle Scholar
• Gottlieb N. L. Comparative pharmacokinetics of parenteral and oral gold compounds. J Rheumatol 1982; 9(suppl. 8)99
   Google Scholar
• Hicks R. M., Hanson V., Kornreich H. K. The use of gold in the treatment of juvenile rheumatoid arthritis (JRA). Arthritis Rheum 1970; 13: 323, (abstract)
   Google Scholar
• Howrie D. L., Gartner J. C., jr. Gold-induced hepatotoxicity: Case report and review of the literature. J Rheumatol 1982; 9: 727
   PubMedGoogle Scholar
• Huskisson E. C., Gibson T. J., Balme H. W., Berry H., Burry H. C., Grahame R., Dudley Hart F., Henderson D. R. F., Wojtulewski J. A. Mal comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report. Ann Rheum Dis 1974; 33: 532
   PubMed Web of Science ®Google Scholar
• Huskisson E. C., Dieppe P. A., Scott J., Trapnell J., Balme H. W., Willoughby D. A. Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet 1976; i: 393
   Google Scholar
• Husserl F. E., Shuler S. E. Gold nephropathy in juvenile rheumatoid arthritis. Am J Dis Child 1979; 133: 50
   PubMedGoogle Scholar
• Kornreich H., Malouf N. N., Hanson V. Acute hepatic dysfunction in juvenile rheumatoid arthritis. J Pediatr 1971; 79: 27
   PubMedGoogle Scholar
• Kvien T. K., Høyeraal H. M., Kåss E. Diagnostic criteria of rheumatoid arthritis in children. Proposed criteria for controlled clinical studies. Scand J Rheumatol 1982; 11: 187
   PubMed Web of Science ®Google Scholar
• Kvien T. K., Høyeraal H. M., Sandstad B. Assessment methods of disease activity in juvenile rheumatoid arthritis—evaluated in a prednisolone/placebo double-blind study. J Rheumatol 1982; 9: 696
   PubMed Web of Science ®Google Scholar
• Kvien T. K., Høyeraal H. M., Sandstad B. Slowacting antirheumatic drugs in patients with juvenile rheumatoid arthriti—valuated in a randomized parallel 50-week clinical trial. J Rheumatol 1985; 12: 533
   PubMed Web of Science ®Google Scholar
• Kvien T. K., Høyeraal H. M., Sandstad B., Kåss E. Oral gold (auranofin) in juvenile rheumatoid arthritis: A 48-week phase II study. Clin Rheumatol 1984; 3: 551
   PubMedGoogle Scholar
• Levinson J. E. Gold salts in the rheumatic diseases. Arthritis in childhood, T. D. Moore. Ross Laboratories, Columbus, Ohio 1981; 120
   Google Scholar
• Mery C., Delrieu F., Ghozlan R., Saporta L., Simon F., Amor B., Menkes C. J., Delbarre F. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc. Scand J Rheumatol 1976; 5: 241
   PubMed Web of Science ®Google Scholar
• Multicentre kid Group: Controlled trial of D(-)penicillamine in severe rheumatoid arthritis. Lancet 1973; i: 275
   Google Scholar
• Miikisara P., Nissila M., Kajander A., Martio J., von Essen R., Anttila P., Makisara G-L. Comparison of penicillamine and gold treatment in early rheumatoid arthritis. Scand J Rheumatol 1978; 7166
   Google Scholar
• Prieur A. M., Piussan C. H., Manigne P., Bordigoni P., Griscelli C. Evaluation of D-penicillamine in juvenile chronic arthritis. A double-blind, multicenter study. Arthritis Rheum 1985; 28: 376
   PubMed Web of Science ®Google Scholar
• Research Sub-committee of the Empire Rheumatism Council. Gold therapy in rheumatoid arthritis. Final report of a multicentre controlled trial. Ann Rheum Dis 1961; 20: 315
   PubMed Web of Science ®Google Scholar
• Sairanen E., Laaksonen A-L. The toxicity of gold therapy in children suffering from rheumatoid arthritis. Ann Paediat Fenn 1962; 8: 105
   PubMedGoogle Scholar
• Sairanen E., Laaksonen A-L. The results of gold therapy in juvenile rheumatoid arthritis. Ann Paediat Fenn 1964; 10: 274
   PubMedGoogle Scholar
• Schairer H., Stoeber E., Kölle G. Vorläufige Befunde einer kontrollierten Studie über Gold-und D-penicillamin-Therapie der kindlichen rheumatoiden Arthritis. Verh Dtsch Ges Rheumatol 1976; 4: 54
   PubMedGoogle Scholar
• Schairer H. Long-term follow-up of 285 cases of juvenile chronic polyarthritis treated with D-penicillamine or gold. The Care of Rheumatic Children, E. Munthe. Eular Publishers, Basle 1978; 165
   Google Scholar
• Shiokawa Y., Horiuchi Y., Honma M., Kageyama T., Okada T., Azuma T. Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum 1977; 20: 1464
   PubMedGoogle Scholar
• Sigler J. W., Bluhm G. B., Duncan H., Sharp J. T., Ensign D. C., McCrum W. R. Gold salts in the treatment of rheumatoid arthritis. A double-blind study. Ann Intern Med 1974; 80: 21
   PubMed Web of Science ®Google Scholar
• Thompson D. M., Pegelow C. H., Singsen B. H., Powars D. R., Hanson V. Neutropenia associated with chrysotherapy for juvenile rheumatoid arthritis. J Pediatr 1978; 93: 871
   PubMedGoogle Scholar
• Walz D. T., Dimartino M. J., Griswold D. E. Comparative pharmacology and biological effects of different gold compounds. J Rheumatol 1982; 9(suyppl. 8)54
   Google Scholar
• Williams H. J., Ward J. R., Reading J. C., Egger M. J., Grandone J. T., Samuelson C. O., Furst D. E., Sullivan J. M., Watson M. A., Guttadauria M., Cathcart E. S., Kaplan S. B., Halla J. T., Weinstein A., Plotz P. H. Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial. Arthritis Rheum 1983; 26: 581
   PubMed Web of Science ®Google Scholar